ArticleBioinformatics (Oxford, England)2026
dAMN: a genome-scale neural-mechanistic hybrid model to predict bacterial growth dynamics.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
summaryThis study presents dAMN, a genome-scale neural-mechanistic hybrid model that combines neural networks with dynamic flux balance analysis to predict bacterial growth dynamics across diverse nutrient environments. Using a residual network architecture, dAMN predicts reaction fluxes and lag-phase parameters from initial medium composition, then integrates these predictions under stoichiometric constraints derived from genome-scale metabolic models. Trained on Escherichia coli and Pseudomonas putida growth datasets across combinatorial media, dAMN accurately forecasts temporal growth dynamics and generalizes to unseen media conditions, with mean R² ≥ 0.9. The model also reproduces biologically relevant behaviors including substrate depletion, acetate overflow, and diauxic shifts, while explicitly modeling lag phases usually absent from standard dFBA. AVAILABILITY AND IMPLEMENTATION: The dAMN software, associated models, and datasets are available at https://github.com/brsynth/dAMN-main-release and via Zenodo DOI: 10.5281/zenodo.17908125.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.